Ligand validation:6ZT9

AHR: alpha-L-arabinofuranose

AHR is a Ligand Of Interest in 6ZT9 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ZT9_AHR_B_501	40%	7%	0.178	0.89	1.77	3	2	8	2	0	100%	1
6ZT9_AHR_A_501	17%	17%	0.271	0.851	0.96	2.58	-	2	1	0	100%	1
6ZT9_AHR_C_501	16%	28%	0.233	0.801	1.09	1.8	-	5	0	0	100%	1
6ZT7_AHR_C_516	28%	13%	0.207	0.86	1.65	2.33	2	5	0	0	100%	1
5OCP_AHR_A_407	97%	41%	0.066	0.978	1.04	1.26	-	1	0	0	100%	0.5
1WD4_AHR_A_602	96%	45%	0.059	0.965	1.21	0.92	-	1	0	0	100%	1
3UG4_AHR_F_487	95%	35%	0.071	0.976	1.63	0.94	2	-	0	0	100%	1
2YDT_AHR_A_501	93%	41%	0.064	0.978	0.97	1.33	-	2	0	0	90%	1
5OPJ_AHR_A_901	87%	4%	0.069	0.941	0.53	4.84	-	8	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.